A Study for G1b CHC Patients With CKD-3 Treated With Grazoprevir Plus Elbasvir
NCT03144635
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
80
Enrollment
OTHER
Sponsor class
Conditions
Hepatitis C Viral
Chronic Kidney Disease stage3
Interventions
DRUG:
Grazoprevir plus Elbasvir
Sponsor
Kyushu University
Collaborators
[object Object]